Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
European Journal of Medicinal Chemistry
|
December 26, 2024
From challenges to solutions: A review of fourth-generation EGFR tyrosine kinase inhibitors to overcome the C797S triple mutation in non-small cell lung cancer
Iqrar Ahmad, Harun M Patel
Drug Development Research
|
December 26, 2024
Orthoallosteric EGFR-TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation
Iqrar Ahmad, Harun M Patel
Journal of Cellular Biochemistry
|
September 20, 2024
Repurposing Non-Nucleosidic Reverse Transcriptase Inhibitors (NNRTIs) to Overcome EGFR T790M-Mediated Acquired Resistance in Non-Small Cell Lung Cancer
Iqrar Ahmad, Harun M Patel
Journal of Basic and Clinical Pharmacy
|
May 15, 2014
3d QSAR studies on a series of quinazoline derrivatives as tyrosine kinase (egfr) inhibitor: the k-nearest neighbor molecular field analysis approach
Malleshappa N Noolvi, Harun M Patel
European Journal of Medicinal Chemistry
|
December 16, 2024
Catalytic Lysine745 targeting strategy in fourth-generation EGFR tyrosine kinase inhibitors to address C797S mutation resistance
Bhatu R Patil, Harun M Patel
Expert Opinion on Therapeutic Patents
|
July 16, 2025
Overcoming triple mutant EGFR-tyrosine kinase barriers in the therapeutics of non-small cell lung cancer: a patent review on fourth-generation inhibitors (2017-2024)
Narendra R Nagpure, Harun M Patel
Chemistry & Biodiversity
|
May 30, 2020
Exploring MDR-TB Inhibitory Potential of 4-Aminoquinazolines as Mycobacterium tuberculosis N-Acetylglucosamine-1-Phosphate Uridyltransferase (GlmU<sup>MTB</sup> ) Inhibitors
Harun M Patel, Mahesh Palkar, Rajshekhar Karpoormath
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
April 14, 2011
A comparative QSAR analysis of quinazoline analogues as tyrosine kinase (erbB-2) inhibitors
Malleshappa N Noolvi, Harun M Patel, Varun Bhardwaj
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
April 26, 2012
A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design
Malleshappa N Noolvi, Harun M Patel, Sarita Kamboj
The Indian Journal of Tuberculosis
|
June 27, 2022
Recent updates in natural terpenoids as potential anti-mycobacterial agents
Vilas R Jagatap, Iqrar Ahmad, Harun M Patel
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
European Journal of Medicinal Chemistry
|
December 26, 2024
From challenges to solutions: A review of fourth-generation EGFR tyrosine kinase inhibitors to overcome the C797S triple mutation in non-small cell lung cancer
Iqrar Ahmad, Harun M Patel
Drug Development Research
|
December 26, 2024
Orthoallosteric EGFR-TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation
Iqrar Ahmad, Harun M Patel
Journal of Cellular Biochemistry
|
September 20, 2024
Repurposing Non-Nucleosidic Reverse Transcriptase Inhibitors (NNRTIs) to Overcome EGFR T790M-Mediated Acquired Resistance in Non-Small Cell Lung Cancer
Iqrar Ahmad, Harun M Patel
Journal of Basic and Clinical Pharmacy
|
May 15, 2014
3d QSAR studies on a series of quinazoline derrivatives as tyrosine kinase (egfr) inhibitor: the k-nearest neighbor molecular field analysis approach
Malleshappa N Noolvi, Harun M Patel
European Journal of Medicinal Chemistry
|
December 16, 2024
Catalytic Lysine745 targeting strategy in fourth-generation EGFR tyrosine kinase inhibitors to address C797S mutation resistance
Bhatu R Patil, Harun M Patel
Expert Opinion on Therapeutic Patents
|
July 16, 2025
Overcoming triple mutant EGFR-tyrosine kinase barriers in the therapeutics of non-small cell lung cancer: a patent review on fourth-generation inhibitors (2017-2024)
Narendra R Nagpure, Harun M Patel
Chemistry & Biodiversity
|
May 30, 2020
Exploring MDR-TB Inhibitory Potential of 4-Aminoquinazolines as Mycobacterium tuberculosis N-Acetylglucosamine-1-Phosphate Uridyltransferase (GlmU<sup>MTB</sup> ) Inhibitors
Harun M Patel, Mahesh Palkar, Rajshekhar Karpoormath
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
April 14, 2011
A comparative QSAR analysis of quinazoline analogues as tyrosine kinase (erbB-2) inhibitors
Malleshappa N Noolvi, Harun M Patel, Varun Bhardwaj
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
April 26, 2012
A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design
Malleshappa N Noolvi, Harun M Patel, Sarita Kamboj
The Indian Journal of Tuberculosis
|
June 27, 2022
Recent updates in natural terpenoids as potential anti-mycobacterial agents
Vilas R Jagatap, Iqrar Ahmad, Harun M Patel
Page
of 7